The board of directors and senior management of each
covered company must consider the results of the analysis conducted
by the Board under this subpart, as appropriate:
(a) As part
of the covered company’s capital plan and capital planning process,
including when making changes to the covered company’s capital structure
(including the level and composition of capital); and
(b) When
assessing the covered company’s exposures, concentrations, and risk
positions.
